CrossCountry Blog Funding, Exits, and Operations: Critical Considerations for Life Sciences Executives in 2025

Rising costs of drug development, evolving regulatory landscapes, and the increasing importance of data and technology continue to shape financial and operational decisions for life sciences executives in 2025. During recent executive discussions, including at the J.P. Morgan Healthcare Conference, leaders at CrossCountry Consulting joined seasoned industry experts to highlight key challenges and opportunities on [...]Source